Karin Herrera
Hoofd Techniek/Wetenschap/O&O bij COMPASS THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Karin Herrera
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Karin Herrera via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
MASTEC, INC. | Engineering & Construction | Comptroller/Controller/Auditor | |
PSYCHEMEDICS CORPORATION | Services to the Health Industry | Director of Finance/CFO | |
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Founder Corporate Officer/Principal | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AVEDRO, INC. | Medical Specialties | Director/Board Member | |
Direct Vet Marketing, Inc.
Direct Vet Marketing, Inc. Information Technology ServicesTechnology Services Direct Vet Marketing, Inc. provides cloud-based prescription management, pharmacy services, marketing solutions and practice analytics for equine and companion animal veterinary practitioners. It offers online ordering and home delivery of prescription drugs, compounded medications, and therapeutic diets. The company was founded by David Evans Shaw and Benjamin J. Shaw in 2010 and is headquartered in Portland, Maine. | Information Technology Services | Director/Board Member | |
TURG POIN | Pharmaceuticals: Major | Director/Board Member | |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
BEACON ROOFING SUPPLY, INC. | Wholesale Distributors | Comptroller/Controller/Auditor | |
Borealis Ventures
Borealis Ventures Investment ManagersFinance Borealis Ventures (Borealis Ventures) is a venture capital firm founded in 2001 by Jesse Devitte and Phil J. Ferneau. The firm is headquartered in Hanover, New Hampshire. | Investment Managers | Founder | |
The University of Colorado | College/University | Undergraduate Degree | |
University of Denver | College/University | Graduate Degree | |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Investment Managers | Consultant / Advisor | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
Avitide, Inc.
Avitide, Inc. BiotechnologyHealth Technology Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member | |
University of Virginia School of Law | College/University | Graduate Degree | |
Johnson & Johnson Consumer BV
Johnson & Johnson Consumer BV Pharmaceuticals: MajorHealth Technology Part of Kenvue, Inc., Johnson & Johnson Consumer BV is a Dutch company that manufactures health care products. The company is based in Almere, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Biotechnology | Director/Board Member | |
KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Gemini Therapeutics Sub, Inc.
Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Atlas TMS | Comptroller/Controller/Auditor | ||
PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
TERNS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
MBX Biosciences, Inc.
MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Frontera Therapeutics (HK) Ltd.
Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Frontera Therapeutics, Inc., Frontera Therapeutics (HK) Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company was founded by Yong Dai and Yong Dai has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member | |
ADICET BIO, INC. | Pharmaceuticals: Major | Chairman | |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Xinthera, Inc.
Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Director/Board Member | |
Gwynant Therapeutics
Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member | |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Electra Therapeutics, Inc. is a clinical stage biotechnology company that develops therapies for the treatment of immunological diseases and cancer. The company is based in San Francisco, CA. The company's lead product candidate, ela026, is a monoclonal antibody that targets sirp on the cell surface of and t cells, and precisely depletes pathological immune cells. Electra currently has one program in clinical development and additional preclinical programs. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
X4 Pharmaceuticals (Austria) GmbH | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 47 |
China | 2 |
Nederland | 2 |
Hongkong | 2 |
Oostenrijk | 2 |
Sectoraal
Health Technology | 29 |
Finance | 6 |
Consumer Services | 6 |
Health Services | 3 |
Technology Services | 3 |
Operationeel
Director/Board Member | 137 |
Independent Dir/Board Member | 46 |
Corporate Officer/Principal | 24 |
Undergraduate Degree | 12 |
Director of Finance/CFO | 9 |
Sterkste connecties
Insiders | |
---|---|
Carl Gordon | 59 |
David Wurzer | 31 |
Mary Gray | 27 |
Phil Ferneau | 20 |
Thomas Schuetz | 17 |
Ellen Chiniara | 16 |
Vered Bisker-Leib | 11 |
James Boylan | 10 |
Richard Lindahl | 9 |
Neil Lerner | 8 |
Minori Rosales | 6 |
Ian Chia | 5 |
Jonathan Anderman | 5 |
Anna Gifford | 1 |
- Beurs
- Insiders
- Karin Herrera
- Bedrijfsconnecties